Facebook Linkedin Youtube X-twitter Instagram
Professional Syndicates Complex, Sharif Abdel Hamid Sharaf Street, 31, Amman, Jordan
About Jordan
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
Login
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
  • من نحن
    • تاريخ الجمعية
    • هيكل الجمعية
    • ادارة الجمعية
    • تطوع معنا
  • العضوية
    • طلب انتساب
    • الاعضاء المنتسبون
    • Types of memberships in the Society of Cardiologists
  • Home
  • نشاطات
  • مواد علمية
  • Health Education
  • جاليري
    • فيديو
    • صور
  • اتصل بنا
Uncategorized
webadmin April 13, 2025 0

Summary: First-in-Man Study Shows Promising Results for world’s first TAVR procedure New Fully Retrievable Valve.

Summary: First-in-Man Study Shows Promising Results for world’s first TAVR procedure New Fully Retrievable Valve.

Source: The American Journal of Cardiology – Click here to read the full analysis
Highlighted by AHA | April 2025

1. Background:
• Traditional self-expanding TAVR valves are only partially retrievable, which may result in malposition or valve migration during final deployment.
• The Venus-PowerX valve, developed by Venus MedTech (China), introduces a fully retrievable and repositionable mechanism even after 100% deployment.
2. Device Features:
• Wire-controlled system enables full recapture.
• Hourglass-shaped frame with supra-annular porcine pericardial leaflets.
• Radiopaque markers and sealing skirt to enhance placement accuracy and reduce paravalvular leak.
• Uses anti-calcification and dry-tissue technologies for long-term durability and room-temperature storage.
3. Study Design – First-in-Human Trial:
• 25 patients with severe aortic stenosis (mean age 75.3 years; 52% female).
• Conducted at two centers in China.
• 52% had bicuspid aortic valve.
• Valve recapture at 80% attempted in 32% of cases — all successful.
• Full recapture at 100% attempted in 8% — all successful.
• 100% procedural and technical success.
4. Outcomes:
• 30-day outcomes:
• 88% device success,
• 20% required permanent pacemaker (linked to RBBB, short membranous septum, 32-mm valve).
• No stroke, MI, valve thrombosis, endocarditis, or CV hospitalization.
• 1-year outcomes:
• 96% survival.
• No stroke, MI, or cardiovascular rehospitalization.
• One non-cardiac death (pneumonia).
• Mean AV gradient dropped from 56 mmHg to 11.6 mmHg.
• Effective orifice area improved from 0.6 cm² to 1.8 cm².
• Only 1 patient had moderate paravalvular leak.
5. Conclusion:
• Venus-PowerX enables precise positioning and reduces risk of migration, leak, and conduction disturbances.
• Dry-tissue technology enhances durability and ease of storage/use.
• Potential to expand TAVR accessibility to resource-limited settings.
• Larger studies are needed to confirm these early findings.

https://www.ajconline.org/article/S0002-9149(25)00200-0/fulltext

156 Views
8
Fluid Restriction Does Not Improve outcomes in Chronic HF.April 13, 2025
Shockwave Medical Co. Launches First-in-Patient Study of Forward IVL Technology for Challenging Calcified Coronary Lesions:April 13, 2025

مقالات ذات صلة

Uncategorized

How pairing SAVR with additional heart surgeries affects mortality risk

jordan heart July 24, 2025
Uncategorized

Mitral Valve Repair vs. Replacement in Infective Endocarditis.

webadmin March 22, 2025

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

احدث المقالات

  • ESC Leads Push for Stronger CE-Mark Evidence on High-Risk Devices
  • TAVR(TAVI in Europe)vs. SAVR —  Cardiologists, heart surgeons sound alarm over widespread use of TAVR in low-risk patients
  • Pediatric Cardiology: The LEAD Initiative — Universal Cholesterol Screening in Children Can Save Lives
  • Vericiguat in Heart Failure – VICTORIA vs VICTOR (ESC 2025)
  • Aspirin and Cancer Prevention

فئات

  • Health Education
  • Previous lectures and conferences
  • Uncategorized

Jordanian Cardiology Society

Jordanian Cardiology Society

Amman-Jordan

00962795001983

Working hours

From Sunday to Thursday

From nine in the morning until four in the afternoon

Important Links

Jordanian Cardiology Society

Research and studies

Medical articles

Login

Privacy Policy

Refund Policy

Cancellation Policy

Delivery Policy

Association Location

Copyright © 2024 Jordanian Cardiologists Association by WebAppRoots. All Rights Reserved.